Holista Colltech Limited ( (AU:HCT) ) has issued an update.
Holista Colltech Limited has appointed Gregory Pilant as a Non-Executive Director to its board, enhancing its leadership in the biotechnology sector. Pilant, the CEO of Regenerex Pharma, brings extensive expertise in regenerative medicine, which aligns with Holista’s focus on health solutions and food sciences. His appointment is part of Holista’s strategic plan to innovate in these areas, and his involvement in the company’s recent funding initiative highlights his commitment to its mission.
More about Holista Colltech Limited
Holista Colltech Ltd is a research-driven biotech company, formed from the merger of Holista Biotech Sdn Bhd and Colltech Australia Ltd. Listed on the Australian Securities Exchange and headquartered in Perth, the company operates in multiple countries, including Malaysia and North America. Holista focuses on developing natural health solutions and advanced technologies related to collagen and nano-collagen, aiming to provide healthier alternatives for food manufacturers without compromising taste.
YTD Price Performance: 210.0%
Average Trading Volume: 244,578
Technical Sentiment Signal: Hold
Current Market Cap: A$8.57M
For detailed information about HCT stock, go to TipRanks’ Stock Analysis page.